 |
Previous Article | Next Article 
The Journal of Neuroscience, 2001, 21:RC168:1-6
RAPID COMMUNICATION
Orexin (Hypocretin) Neurons Contain Dynorphin
Thomas C.
Chou1,
Charlotte E.
Lee2,
J.
Lu3,
Joel K.
Elmquist2,
Junko
Hara5,
Jon T.
Willie4,
Carsten T.
Beuckmann4,
Richard M.
Chemelli4,
Takeshi
Sakurai5,
Masashi
Yanagisawa4,
Clifford B.
Saper1, 3, and
Thomas E.
Scammell3
1 Department of Neurobiology and Program in
Neuroscience, Harvard Medical School, Boston, Massachusetts 02115, Departments of 2 Endocrinology and 3 Neurology,
Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115, 4 Howard Hughes Medical Institute and Department of
Molecular Genetics, University of Texas Southwestern Medical Center at
Dallas, Dallas, Texas 75390, and 5 Department of
Pharmacology, Institute of Basic Medical Sciences, University of
Tsukuba, Tsukuba, Ibaraki 305-8575, Japan
Orexins (also called hypocretins) are peptide neurotransmitters
expressed in neurons of the lateral hypothalamic area (LHA). Mice
lacking the orexin peptides develop narcolepsy-like symptoms, whereas
mice with a selective loss of the orexin neurons develop hypophagia and
severe obesity in addition to the narcolepsy phenotype. These different
phenotypes suggest that orexin neurons may contain neurotransmitters
besides orexin that regulate feeding and energy balance. Dynorphin
neurons are common in the LHA, and dynorphin has been shown to
influence feeding; hence, we studied whether dynorphin and orexin are
colocalized. In rats, double-label in situ hybridization
revealed that nearly all (94%) neurons expressing prepro-orexin mRNA
also expressed prodynorphin mRNA. The converse was also true: 96% of
neurons in the LHA containing prodynorphin mRNA also expressed
prepro-orexin mRNA. Double-label immunohistochemistry confirmed that
orexin-A and dynorphin-A peptides were highly colocalized in the LHA.
Wild-type mice and orexin knock-out mice showed abundant prodynorphin
mRNA-expressing neurons in the LHA, but orexin/ataxin-3 mice with a
selective loss of the orexin neurons completely lacked prodynorphin
mRNA in this area, further confirming that within the LHA, dynorphin
expression is restricted to the orexin neurons. These findings suggest
that dynorphin-A may play an important role in the function of the
orexin neurons.
Key words:
orexin; hypocretin; dynorphin; narcolepsy; obesity; feeding
Copyright © Society for Neuroscience 0270-6474//$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
N. Tsujino and T. Sakurai
Orexin/Hypocretin: A Neuropeptide at the Interface of Sleep, Energy Homeostasis, and Reward System
Pharmacol. Rev.,
June 1, 2009;
61(2):
162 - 176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Parmentier, S. Kolbaev, B. P. Klyuch, D. Vandael, J.-S. Lin, O. Selbach, H. L. Haas, and O. A. Sergeeva
Excitation of Histaminergic Tuberomamillary Neurons by Thyrotropin-Releasing Hormone
J. Neurosci.,
April 8, 2009;
29(14):
4471 - 4483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Diniz Behn, N. Kopell, E. N. Brown, T. Mochizuki, and T. E. Scammell
Delayed Orexin Signaling Consolidates Wakefulness and Sleep: Physiology and Modeling
J Neurophysiol,
June 1, 2008;
99(6):
3090 - 3103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Zhang, J. M. Zeitzer, T. Sakurai, S. Nishino, and E. Mignot
Sleep/wake fragmentation disrupts metabolism in a mouse model of narcolepsy
J. Physiol.,
June 1, 2007;
581(2):
649 - 663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.-Q. Chang, O. Karatayev, R. Ahsan, V. Gaysinskaya, Z. Marwil, and S. F. Leibowitz
Dietary fat stimulates endogenous enkephalin and dynorphin in the paraventricular nucleus: role of circulating triglycerides
Am J Physiol Endocrinol Metab,
February 1, 2007;
292(2):
E561 - E570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zhang, T. Sakurai, Y. Fukuda, and T. Kuwaki
Orexin neuron-mediated skeletal muscle vasodilation and shift of baroreflex during defense response in mice
Am J Physiol Regulatory Integrative Comp Physiol,
June 1, 2006;
290(6):
R1654 - R1663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Crocker, R. A. Espana, M. Papadopoulou, C. B. Saper, J. Faraco, T. Sakurai, M. Honda, E. Mignot, and T. E. Scammell
Concomitant loss of dynorphin, NARP, and orexin in narcolepsy
Neurology,
October 25, 2005;
65(8):
1184 - 1188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Blouin, T. C. Thannickal, P. F. Worley, J. M. Baraban, I. M. Reti, and J. M. Siegel
Narp immunostaining of human hypocretin (orexin) neurons: Loss in narcolepsy
Neurology,
October 25, 2005;
65(8):
1189 - 1192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Margolis, G. O. Hjelmstad, A. Bonci, and H. L. Fields
Both Kappa and Mu Opioid Agonists Inhibit Glutamatergic Input to Ventral Tegmental Area Neurons
J Neurophysiol,
June 1, 2005;
93(6):
3086 - 3093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. T. Beuckmann, C. M. Sinton, S. C. Williams, J. A. Richardson, R. E. Hammer, T. Sakurai, and M. Yanagisawa
Expression of a Poly-Glutamine-Ataxin-3 Transgene in Orexin Neurons Induces Narcolepsy-Cataplexy in the Rat
J. Neurosci.,
May 5, 2004;
24(18):
4469 - 4477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Wichniak, H. Brunner, E. Friess, and T. Pollmacher
Successful suppression of cataplectic attacks with tramadol
Neurology,
September 23, 2003;
61(6):
864 - 865.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Thorpe, M. A. Mullett, C. Wang, and C. M. Kotz
Peptides that Regulate Food Intake: Regional, metabolic, and circadian specificity of lateral hypothalamic orexin A feeding stimulation
Am J Physiol Regulatory Integrative Comp Physiol,
June 1, 2003;
284(6):
R1409 - R1417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zheng, M. Corkern, I. Stoyanova, L. M. Patterson, R. Tian, and H.-R. Berthoud
Peptides that Regulate Food Intake: Appetite-inducing accumbens manipulation activates hypothalamic orexin neurons and inhibits POMC neurons
Am J Physiol Regulatory Integrative Comp Physiol,
June 1, 2003;
284(6):
R1436 - R1444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Georgescu, V. Zachariou, M. Barrot, M. Mieda, J. T. Willie, A. J. Eisch, M. Yanagisawa, E. J. Nestler, and R. J. DiLeone
Involvement of the Lateral Hypothalamic Peptide Orexin in Morphine Dependence and Withdrawal
J. Neurosci.,
April 15, 2003;
23(8):
3106 - 3111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ouedraogo, E. Naslund, and A. L. Kirchgessner
Glucose Regulates the Release of Orexin-A From the Endocrine Pancreas
Diabetes,
January 1, 2003;
52(1):
111 - 117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Kukkonen, T. Holmqvist, S. Ammoun, and K. E. O. Akerman
Functions of the orexinergic/hypocretinergic system
Am J Physiol Cell Physiol,
December 1, 2002;
283(6):
C1567 - C1591.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Fadel, M. Bubser, and A. Y. Deutch
Differential Activation of Orexin Neurons by Antipsychotic Drugs Associated with Weight Gain
J. Neurosci.,
August 1, 2002;
22(15):
6742 - 6746.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Wang and C. M. Kotz
Urocortin in the lateral septal area modulates feeding induced by orexin A in the lateral hypothalamus
Am J Physiol Regulatory Integrative Comp Physiol,
August 1, 2002;
283(2):
R358 - R367.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|